NextCure (NXTC) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order virtually, chaired by David Kabakoff, with four agenda items: director elections, auditor ratification, executive compensation approval, and amendment of the 2019 Omnibus Incentive Plan.

• Stockholders invited to comment or ask questions via the meeting website, with procedures outlined for participation.

Board and executive committee updates

• Board members and executive officers present were introduced, including the CEO, COO, CFO, and General Counsel.

• Tom Sand from Ernst & Young and Beth VanDerbeck as Inspector of Election were also present.

Shareholder proposals

• Proposals included election of two Class I directors for three-year terms, ratification of Ernst & Young as auditors, advisory approval of executive compensation, and amendment/restatement of the 2019 Omnibus Incentive Plan.

• Board unanimously recommended approval of all proposals.